IQVIA Hldgs Analyst Ratings
Catalent Analyst Ratings
Charles River Analyst Ratings
Barclays Lowers Price Target on IQVIA Holdings to $255 From $275
Barclays Adjusts Catalent Price Target to $63 From $47
Charles River Analyst Ratings
IQVIA Hldgs Analyst Ratings
Icon Analyst Ratings
Charles River Analyst Ratings
Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target
HSBC Adjusts Price Target on Laboratory Corp of America Holdings to $210 From $225, Keeps Hold Rating
Icon Analyst Ratings
Labcorp Holdings Analyst Ratings
Quest Diagnostics Analyst Ratings
JPMorgan Adjusts Price Target on Quest Diagnostics to $155 From $152
JPMorgan Adjusts Price Target on Laboratory Corp of America Holdings to $243 From $261
IQVIA Holdings (IQV) Gets a Buy From Jefferies
Baird Adjusts Price Target on Laboratory Corp of America Holdings to $256 From $255, Keeps Outperform Rating
Argus Adjusts Price Target on Quest Diagnostics to $215 From $163, Keeps Buy Rating
Argus Raises Quest Diagnostics' Price Target to $163 From $155